As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...
With me today on the call, we have Mr. Rafi Amit, Camtek's CEO; Mr. Before you buy stock in Camtek, consider this: The Motley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback